UTERINE FIBROIDS: AN INTEGRATIVE REVIEW ON CLINICAL AND SURGICAL MANAGEMENT OPTIONS

Abstract

Uterine leiomyoma, known as myoma, is a benign tumor that affects a significant portion of women of reproductive age. Its high incidence, which can reach 40%, makes this condition a relevant medical and social challenge. Its origin is related to the clonal expansion of a single cell in the uterine myometrium, although the exact pathogenetic mechanisms are still not fully understood. This article consists of an integrative review, in which it aims to discuss the options for clinical and surgical treatment for uterine fibroids, through considerations about the pathology, in order to expand the knowledge of society and of students and professionals in the area about the topic in question. The work consists of an integrative literature review, in which a search was carried out in the databases. Regarding oral contraceptives, there is no evidence that they are effective in the treatment of uterine fibroids. However, it is important to highlight that they are effective in controlling and correcting dysfunctional uterine bleeding. Definitive treatment for symptomatic myomatosis is usually surgical. Hysterectomy, which involves removal of the uterus, is one of the main therapeutic options. In short, uterine fibroids are a common condition that can significantly affect women's quality of life. Medical and surgical management options offer a variety of therapeutic approaches, each with its own benefits and considerations.